MedPage Today March 4, 2022
— Onshoring can’t be the whole response, says report from NASEM
WASHINGTON — Onshoring medical manufacturing is part of a strategy to shore up the nation’s medical supply chain, but it can’t be the entire strategy, according to a new report from the National Academies of Sciences, Engineering, and Medicine (NASEM).
“If you are thinking about onshoring the entire global supply chain, that would be a daunting logistical task, and associated with a huge price tag as well,” said Ozlem Ergun, PhD, professor of mechanical and industrial engineering at Northeastern University in Boston. “Onshoring can be part of a cost-effective strategy for increasing resiliency of our medical product supply chains — however, it should be treated as part of a...
Today's Sponsors
Today's Sponsor